Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.100
-0.020 (-0.94%)
At close: Nov 13, 2026, 4:00 PM EST
2.140
+0.040 (1.90%)
After-hours: Nov 13, 2026, 7:54 PM EST
Compugen Market Cap
Compugen has a market cap or net worth of $198.92 million as of November 13, 2026. It is the 20,500th most valuable company in the world and the 3,522nd biggest in the United States. Its market cap has increased by 26.62% in one year.
Market Cap
198.92M
Enterprise Value
84.18M
1-Year Change
26.62%
Global Rank
Country Rank
#3,522 United States
Category
ChartMarket Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $198.92M, an increase of 327.79%. That is a compound annual growth rate of 6.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 199.00M | 39.06% |
| Dec 31, 2025 | 143.10M | 4.45% |
| Dec 31, 2024 | 137.00M | -21.58% |
| Dec 29, 2023 | 174.70M | 181.77% |
| Dec 30, 2022 | 62.00M | -82.82% |
| Dec 31, 2021 | 360.80M | -64.38% |
| Dec 31, 2020 | 1.01B | 183.96% |
| Dec 31, 2019 | 356.70M | 220.49% |
| Dec 31, 2018 | 111.30M | -12.91% |
| Dec 29, 2017 | 127.80M | -50.45% |
| Dec 30, 2016 | 257.90M | -19.68% |
| Dec 31, 2015 | 321.10M | -5.97% |
| Dec 31, 2014 | 341.50M | 4.27% |
| Dec 31, 2013 | 327.50M | 91.74% |
| Dec 31, 2012 | 170.80M | 1.73% |
| Dec 30, 2011 | 167.90M | 3.83% |
| Dec 31, 2010 | 161.70M | 16.92% |
| Dec 31, 2009 | 138.30M | 1,033.61% |
| Dec 31, 2008 | 12.20M | -72.95% |
| Dec 31, 2007 | 45.10M | -37.45% |
| Dec 29, 2006 | 72.10M | -38.95% |
| Dec 30, 2005 | 118.10M | -14.61% |
| Dec 31, 2004 | 138.30M | 4.38% |
| Dec 31, 2003 | 132.50M | 184.95% |
| Dec 31, 2002 | 46.50M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 207.57M |
| BridgeBio Oncology Therapeutics | 205.25M |
| Artiva Biotherapeutics | 201.19M |
| Entrada Therapeutics | 198.60M |
| Korro Bio | 197.79M |
| MediWound | 197.49M |
| Pyxis Oncology | 195.91M |
| Fate Therapeutics | 192.31M |